Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patients

2002 ◽  
Vol 58 (2) ◽  
pp. 137-141 ◽  
Author(s):  
Anne Lamminpää ◽  
Eero Pukkala ◽  
Lyly Teppo ◽  
Pertti J. Neuvonen
GastroHep ◽  
2021 ◽  
Vol 3 (2) ◽  
pp. 107-115
Author(s):  
Inka Koskinen ◽  
Kaisa Hervonen ◽  
Eero Pukkala ◽  
Timo Reunala ◽  
Katri Kaukinen ◽  
...  

2021 ◽  
Vol 19 (2) ◽  
pp. 221-228
Author(s):  
Roza M. Shaimardanova ◽  
Rimma G. Gamirova

AIM: To conduct a retrospective comparative analysis of the efficacy and safety of epilepsy therapy with antiepileptic drugs. MATERIALS AND METHODS: The analysis of the treatment of 428 patients with epilepsy at the Childrens City Hospital No. 8 in Kazan, receiving antiepileptic drugs. RESULTS: It was found that valproic acid is more effective in the treatment of idiopathic generalized epilepsies compared to focal epilepsies (p = 0.0006). Valproate and carbamazepine were the most effective in the treatment of focal epilepsy with short- and long-term follow-up. Valproic acid is more effective than topiramate (p = 0.02), oxcarbazepine (p = 0.003), and levetiracetam (p = 0.003) in the treatment of focal epilepsy in short- and long-term follow-up. Carbamazepine is more effective than topiramate (p = 0.01), oxcarbazepine (p = 0.02), and levetiracetam (p = 0.001) in the treatment of focal epilepsy in long-term follow-up. It was revealed that more often they complained about side effects when using carbamazepine (63.2%). Levetiracetam was found to be better tolerated compared to valproate (p = 0.0006) and carbamazepine (p = 0.0006). Topiramate is better tolerated than carbamazepine (p = 0.02) and valproate (p = 0.03). Oxcarbazepine is better tolerated than carbamazepine in women (p = 0.04). CONCLUSIONS: When choosing an antiepileptic drug, it is necessary to be guided by the principle: first the basic, and then the drugs of the next generations, in the future, rely on information about the tolerability of the drug. It is necessary to evaluate the therapeutic effect of antiepileptic drugs with long-term observation, and use the criterion of complete absence of seizures as an indicator of the effectiveness of drugs.


2020 ◽  
Vol 73 ◽  
pp. S557-S558
Author(s):  
Thomas Kallab ◽  
Benedikt Schaefer ◽  
André Viveiros ◽  
Bernhard Pfeifer ◽  
Florian Kronenberg ◽  
...  

2009 ◽  
Vol 44 (4) ◽  
pp. 387-391 ◽  
Author(s):  
L. C. Thygesen ◽  
P. Mikkelsen ◽  
T. V. Andersen ◽  
H. Tonnesen ◽  
K. Juel ◽  
...  

2019 ◽  
Vol 155 ◽  
pp. 106148 ◽  
Author(s):  
Cecilie Johannessen Landmark ◽  
Ida Fløgstad ◽  
Arton Baftiu ◽  
Marte Syvertsen ◽  
Ulla Enger ◽  
...  

2017 ◽  
Vol 4 ◽  
pp. 2329048X1771596 ◽  
Author(s):  
Jing Chen ◽  
Guo Zheng ◽  
Hu Guo ◽  
Xiaopeng Lu ◽  
Chunfeng Wu ◽  
...  

Objective: To investigate the clinical and neurophysiological characteristics of epileptic negative myoclonus as the first and only ictal symptom of benign epilepsy with centrotemporal spikes. Methods: Electrophysiological evaluations included polygraphic recordings with simultaneous video electroencephalogram monitoring and tests performed with patient’s upper limb outstretched in standing posture. Epileptic negative myoclonus manifestations, electrophysiological features, and responses to antiepileptic drugs were analyzed. Results: The authors report 2 patients with benign epilepsy with centrotemporal spikes, who had epileptic negative myoclonus as the first and only seizure type. Video electroencephalogram monitoring results showed that their negative myoclonus seizures were emanating from the contralateral central and the parietal regions. Epileptic negative myoclonus was controlled by administration of valproate and levetiracetam. Conclusion: Epileptic negative myoclonus can be the first and only seizure type of benign epilepsy with centrotemporal spikes, and long-term follow-up monitoring should be the care for the recurrence and/or presence of other types of seizures.


Sign in / Sign up

Export Citation Format

Share Document